Majid Mokhtari
Overview
Explore the profile of Majid Mokhtari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zangi M, Asadi Anar M, Amirdosara M, Mokhtari M, Goharani R, Sanei Moghaddam S, et al.
Anesth Pain Med
. 2025 Mar;
14(5):e146811.
PMID: 40078655
Context: The enhanced recovery after surgery (ERAS) protocol is a multidisciplinary approach aimed at improving surgical outcomes, reducing complications, minimizing hospital stays, and lowering healthcare costs. Objectives: This study assesses...
2.
Jamaati H, Karimi S, Arshi S, Zahraei S, Panahi Y, Nouri F, et al.
Front Immunol
. 2025 Mar;
16:1504973.
PMID: 40028315
Introduction: The global coronavirus disease 2019 (COVID-19) pandemic necessitated urgent vaccine development, raising concerns about potential vaccine adverse events (AEs). Methods: In this prospective cohort study, conducted from February 2021...
3.
Boosalik Z, Khodaei K, Ghoreishi S, Rezazadeh B, Mokhtari M, Tabani H
Mar Pollut Bull
. 2024 Oct;
209(Pt A):117076.
PMID: 39413477
This research focuses on an Iranian industrial area with a long history of oil contamination where oil spills occurred over time. Multiple techniques were utilized to determine the contamination source,...
4.
Khosravi Shadmani F, Moradi G, Naghipour M, Asadi F, Ahmadi A, Mirahmadizadeh A, et al.
Front Immunol
. 2024 Sep;
15:1420651.
PMID: 39234259
Introduction: This study measures the COVID-19 vaccine effectiveness (CVE) against hospital admission and severe COVID-19. Methods: This study is a test-negative case-control design using data from eight provinces in April,...
5.
Badi K, Hajiesmaeili M, Mokhtari M, Goharani R, Amirdosara M, Zangi M
Turk Neurosurg
. 2024 Jun;
34(4):573-577.
PMID: 38874234
Aim: To describe the time between external ventricular drain (EVD) implantation and mobilization in neurosurgery intensive care unit (ICU) patients with EVDs. Due to increased intracranial pressure, neurosurgery patients with...
6.
Mokhtari M, Khoshbakht S, Ziyaei K, Akbari M, Moravveji S
Brief Bioinform
. 2024 Mar;
25(2).
PMID: 38446742
Bioinformatics has revolutionized biology and medicine by using computational methods to analyze and interpret biological data. Quantum mechanics has recently emerged as a promising tool for the analysis of biological...
7.
Ziyaei K, Mokhtari M, Hashemi M, Rezaei K, Abdi F
Sci Total Environ
. 2024 Feb;
924:171261.
PMID: 38417520
The recent scientific focus on polycyclic aromatic hydrocarbons (PAHs) has stemmed from their recognized genotoxic, mutagenic, and carcinogenic properties. This systematic review seeks to evaluate the nexus between exposure to...
8.
Mokhtari M, Khoshbakht S, Akbari M, Moravveji S
BMC Med Genomics
. 2024 Jan;
17(1):13.
PMID: 38172948
No abstract available.
9.
Mokhtari M, Khoshbakht S, Akbari M, Sayyed Sajjad M
Heliyon
. 2023 Dec;
9(12):e22874.
PMID: 38125536
Background: The gene has been linked to promoting metastasis in breast cancer (BC) cells, and low expression reduces invasion potential. Circular RNAs (circRNAs) function as microRNA (miRNA) modulators and are...
10.
Mokhtari M, Khoshbakht S, Akbari M, Moravveji S
BMC Med Genomics
. 2023 Dec;
16(1):328.
PMID: 38087279
Background: In recent years, drug screening has been one of the most significant challenges in the field of personalized medicine, particularly in cancer treatment. However, several new platforms have been...